Atsuko Watanabe
Comptroller/Controller/Auditor chez HanaVax, Inc.
Postes actifs de Atsuko Watanabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01/11/2018 | - |
Historique de carrière de Atsuko Watanabe
Anciens postes connus de Atsuko Watanabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Directeur/Membre du Conseil | 01/06/2019 | - |
| Corporate Officer/Principal | 01/05/2019 | - |
Statistiques
Internationale
| Japon | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Atsuko Watanabe
- Expérience
